Intriguingly, in gastrointestinal cancers, MAEA overexpression paradoxically enhances chemosensitivity via promoting PARP1 ubiquitination and degradation, suggesting that MAEA’s influence on chemotherapy response is tumor type- and context-specific (54). The gene discussed is MAEA; the disease is neoplasm.